United States (US) Attention Deficit Hyperactivity Disorder Market (2025-2031) | Trends, Analysis, Share, Growth, Segmentation, Companies, Value, Size & Revenue, Industry, Outlook, Competitive Landscape, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Attention Deficit Hyperactivity Disorder Market - Industry Life Cycle

3.4 United States (US) Attention Deficit Hyperactivity Disorder Market - Porter's Five Forces

3.5 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume Share, By Demographics, 2021 & 2031F

3.7 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness and diagnosis rates of ADHD in the United States

4.2.2 Growing research and development activities leading to new and improved treatment options

4.2.3 Rising demand for non-stimulant medications due to concerns about the side effects of stimulant drugs

4.3 Market Restraints

4.3.1 Stringent regulatory requirements for the approval of new ADHD treatments

4.3.2 Limited access to specialized healthcare professionals for accurate diagnosis and treatment

4.3.3 Stigma associated with ADHD leading to underreporting and undertreatment

6.1 United States (US) Attention Deficit Hyperactivity Disorder Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume, By Stimulants, 2021- 2031F

6.1.4 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume, By Non-stimulants, 2021- 2031F

6.2 United States (US) Attention Deficit Hyperactivity Disorder Market, By Demographics

6.2.1 Overview and Analysis

6.2.2 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume, By Children, 2021- 2031F

6.2.3 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume, By Adults, 2021- 2031F

6.3 United States (US) Attention Deficit Hyperactivity Disorder Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F

6.3.3 United States (US) Attention Deficit Hyperactivity Disorder Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F

7.1 United States (US) Attention Deficit Hyperactivity Disorder Market Export to Major Countries

7.2 United States (US) Attention Deficit Hyperactivity Disorder Market Imports from Major Countries

8.1 Number of clinical trials for new ADHD treatments

8.2 Percentage of healthcare providers trained in ADHD diagnosis and treatment

8.3 Patient adherence rates to ADHD medication therapy

9.1 United States (US) Attention Deficit Hyperactivity Disorder Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 United States (US) Attention Deficit Hyperactivity Disorder Market Opportunity Assessment, By Demographics, 2021 & 2031F

9.3 United States (US) Attention Deficit Hyperactivity Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10.1 United States (US) Attention Deficit Hyperactivity Disorder Market Revenue Share, By Companies, 2024

10.2 United States (US) Attention Deficit Hyperactivity Disorder Market Competitive Benchmarking, By Operating and Technical Parameters